Johns Hopkins Reports Promising Clinical Data in COVID-19 ARDS Treated with Cellenkos’ Cord Blood T-Regulatory Cells
Physician-investigators at Johns Hopkins University Hospital report on the promising data of treatment of COVID-19 induced acute respiratory distress syndrome with allogeneic, cord blood derived T-regulatory (Treg) cell therapy (manufactured by Cellenkos®), published in peer reviewed journal of Annals of Internal Medicine.
